Review article
Modeling neurodegenerative disorders in zebrafish

https://doi.org/10.1016/j.neubiorev.2022.104679Get rights and content

Highlights

  • Zebrafish is a highly relevant model species in neurodegenerative research.

  • Zebrafish models can help clarify key pathogenic mechanisms of neurodegeneration.

  • Neurodegenerative disorders have evolutionarily conserved mechanisms across taxa.

  • Neurodegeneration involves complex genetic and molecular deficits across taxa.

Abstract

Neurodegeneration is a major cause of Alzheimer’s, Parkinson’s, Huntington’s, multiple and amyotrophic lateral sclerosis, pontocerebellar hypoplasia, dementia and other related brain disorders. Their complex pathogenesis commonly includes genetic and neurochemical deficits, misfolded protein toxicity, demyelination, apoptosis and mitochondrial dysfunctions. Albeit differing in specific underlying mechanisms, neurodegenerative disorders typically display evolutionarily conserved mechanisms across taxa. Here, we review the role of zebrafish models in recapitulating major human and rodent neurodegenerative conditions, demonstrating this species as a highly relevant experimental model for research on neurodegenerative diseases, and discussing how these fish models can further clarify the underlying genetic, neurochemical, neuroanatomical and behavioral pathogenic mechanisms.

Introduction

Neurodegeneration is the main cause of several widespread and debilitating disorders, including Alzheimer’s (AD), Parkinson’s (PD) and Huntington’s diseases (HD), as well as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), dementia and other related brain disorders (Agrawal and Biswas, 2015, Chi et al., 2018, Muddapu et al., 2020, Zhou et al., 2022). Their most common clinical symptoms are progressive cognitive and motor deficits (Katsuno et al., 2018) caused by excessive accumulation and aggregation of disease-specific misfolded proteins (Skovronsky et al., 2006), excessive oxidation (induced by free radicals or mitochondrial dysfunction), neuroinflammation and demyelination (Jellinger, 2010). However, the underlying mechanisms of neurodegenerative disorders are complex and remain poorly understood, necessitating further mechanistic studies and the use of animal (experimental) models (McArthur and Borsini, 2008, McGonigle, 2014).

While rodents are presently the most commonly used species for modeling neurodegenerative disorders (Emborg, 2017, Verdier et al., 2015), the zebrafish (Danio rerio) emerges as an important animal model that can be also used to probe molecular and physiological mechanisms of neurodegeneration. These fish are characterized by easily trackable behavioral patterns, shared central nervous system (CNS) and endocrine physiology, fully sequenced genome, high genetic homology with mammals, rapid neurodevelopment, and high potential for pharmacological (De Abreu et al., 2020, Goldsmith, 2004) and genetic manipulations (Choi et al., 2021, Kalueff et al., 2014, Norton and Bally-Cuif, 2010).

Furthermore, zebrafish present some additional practical and methodological advantages (compared to rodent or other vertebrate and invertebrate (e.g., Caenorhabditis elegans) models), including their easier maintenance vs. mammals (Detrich Iii et al., 1998), external fertilization, rapid development, ease of the observation and experimental manipulation of the embryos, as well as the optical clarity of the embryos and even some adult fish strains, hence enabling visualization of individual genes (e.g., fluorescently labeled or dyed) throughout the developmental process using non-invasive imaging techniques (Araya et al., 2016, Tang et al., 2020). Zebrafish also possess a similar (to other vertebrates, including humans) neural structural organization and high genetic homology with human genes involved in clinical AD and other neurodegenerative disorders (Ebrahimie et al., 2017, Kumar et al., 2021, Razali et al., 2021) (see Table 1 for details).

Taken together, all these aspects make zebrafish a particularly promising translational model system for studying CNS disorders, including neurodegenerative diseases. Recognizing this rapidly developing field, here we review zebrafish-based neurodegenerative models, and discuss how they may improve our understanding of various pathobiological aspects of neurodegeneration and its role in human brain disorders.

Section snippets

Alzheimer’s disease (AD)

AD is the most common cause of dementia, caused by accumulating senile plaques (SP) that contain extracellular amyloid beta (Aβ) and neurofibrillary tangles (NFT) of intracellular hyperphosphorylated tau-protein (Goedert, 1993, Hardy and Higgins, 1992, Selkoe and Hardy, 2016). AD includes the early-onset (˂65 years) familial (FAD), and the late-onset (>65 years) sporadic (SAD) subtypes. FAD (Qiu et al., 2009) is associated with mutant APP (Aβ precursor protein), PSEN (Presenelin)1 and PSEN2

Discussion

Mounting evidence summarized here suggests zebrafish as a promising model species to study a wide range of human neurodegenerative disorders. Indeed, zebrafish often parallel and recapitulate rodent models of these disorders, hence often offering a more throughput, less time-consuming and cheaper complementary screening system, compared to traditional rodent models. The possibility to model neurodegenerative disorders in a different taxon (fish vs. mammals) is also important, since it enables

Acknowledgements

This study is supported by the Russian Science Foundation grant № 20-65-46006. The authors declare no conflicts of interest. KNZ was supported by Sirius University of Science and Technology, Sochi, Russia (project ID NRB-RND-2116). KAD and AVK were supported by St. Petersburg State University budget funds (Project ID 93020614). The study partially used the facilities and equipment of the Resource Fund of Applied Genetics MIPT (support grant 075-15-2021-684).

References (284)

  • A.L. Croxford et al.

    Mouse models for multiple sclerosis: historical facts and future implications

    Biochim. Biophys. Acta (BBA) Mol. Basis Dis.

    (2011)
  • M.S. De Abreu et al.

    Non-pharmacological and pharmacological approaches for psychiatric disorders: re-appraisal and insights from zebrafish models

    Pharmacol. Biochem. Behav.

    (2020)
  • M. DeJesus-Hernandez et al.

    Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

    Neuron

    (2011)
  • P.M. Eimon

    Studying apoptosis in the zebrafish

    Methods Enzymol.

    (2014)
  • M.M. Evers et al.

    Antisense oligonucleotides in therapy for neurodegenerative disorders

    Adv. Drug Deliv. Rev.

    (2015)
  • A. Federico et al.

    Mitochondria, oxidative stress and neurodegeneration

    J. Neurol. Sci.

    (2012)
  • R. Francis et al.

    aph-1 and pen-2 are required for notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation

    Dev. Cell

    (2002)
  • R.W. Friedrich et al.

    Circuit neuroscience in zebrafish

    Curr. Biol.

    (2010)
  • M. Goedert

    Tau protein and the neurofibrillary pathology of Alzheimer’s disease

    Trends Neurosci.

    (1993)
  • P. Goldsmith

    Zebrafish as a pharmacological tool: the how, why and when

    Curr. Opin. Pharmacol.

    (2004)
  • S.L. Hauser et al.

    The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration

    Neuron

    (2006)
  • P. Joshi et al.

    Amyloid precursor protein is required for convergent-extension movements during Zebrafish development

    Dev. Biol.

    (2009)
  • A.V. Kalueff et al.

    Zebrafish as an emerging model for studying complex brain disorders

    Trends Pharmacol. Sci.

    (2014)
  • Ababneh, N., Scaber, J., Flynn, R., Douglas, A., Turner, M.R., Sims, D., Dafinca, R., Cowley, S.A., Talbot, K., 2019....
  • M. Agrawal et al.

    Molecular diagnostics of neurodegenerative disorders

    Front. Mol. Biosci.

    (2015)
  • V.T.E. Aho et al.

    Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease

    Mol. Neurodegener.

    (2021)
  • Alyenbaawi, H., Kanyo, R., Locskai, L.F., Kamali-Jamil, R., DuVal, M.G., Bai, Q., Wille, H., Burton, E.A., Allison,...
  • P.M. Andersen et al.

    Phenotype in an Infant with SOD1 Homozygous Truncating Mutation

    N. Engl. J. Med.

    (2019)
  • O. Anichtchik et al.

    Loss of PINK1 function affects development and results in neurodegeneration in zebrafish

    J. Neurosci.

    (2008)
  • O.V. Anichtchik et al.

    Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6–hydroxydopamine and 1–methyl‐4–phenyl‐1, 2, 3, 6–tetrahydropyridine

    J. Neurochem.

    (2004)
  • B. Appelhof et al.

    Classification of Pontocerebellar Hypoplasia: Where does it End?

    EMJ Neurol

    (2019)
  • C. Araya et al.

    Coordinating cell and tissue behavior during zebrafish neural tube morphogenesis

    Dev. Dyn.

    (2016)
  • B.S. Ashok et al.

    Hypoxia-inducible factors as neuroprotective agent in Alzheimer’s disease

    Clin. Exp. Pharmacol. Physiol.

    (2017)
  • J. Avila et al.

    Role of tau protein in both physiological and pathological conditions

    Physiol. Rev.

    (2004)
  • Babin, P.J., Thisse, C., Durliat, M., Andre, M., Akimenko, M.-A., Thisse, B., 1997. Both apolipoprotein E and A-I genes...
  • S. Bagnato et al.

    Moderate/severe traumatic brain injury as a trigger of chronic neurodegeneration in humans

    Neural Regener. Research

    (2020)
  • Q. Bai et al.

    Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene

    Nucleic Acids Res.

    (2007)
  • P.G. Barth et al.

    Pontocerebellar hypoplasia type 2: a neuropathological update

    Acta Neuropathol.

    (2007)
  • A.A.O. Bashirzade et al.

    MPTP-treated zebrafish recapitulate ‘late-stage’Parkinson’s-like cognitive decline

    Toxics

    (2022)
  • M. Basson et al.

    Congenital hypoplasia of the cerebellum: developmental causes and behavioral consequences

    Front. Neuroanat.

    (2013)
  • M.F. Beal et al.

    Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

    Nature

    (1986)
  • P. Bhattarai et al.

    Modeling amyloid-β42 toxicity and neurodegeneration in adult zebrafish brain

    J. Vis. Exp.

    (2017)
  • P. Bhattarai et al.

    The effects of aging on Amyloid-β42-induced neurodegeneration and regeneration in adult zebrafish brain

    Neurogenesis

    (2017)
  • V. Bonifati et al.

    DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism

    Neurol. Sci.

    (2003)
  • A.W. Boyden et al.

    Novel B cell-dependent multiple sclerosis model using extracellular domains of myelin proteolipid protein

    Sci. Rep.

    (2020)
  • M.C. Braunisch et al.

    Extension of the phenotype of biallelic loss-of-function mutations in SLC25A46 to the severe form of pontocerebellar hypoplasia type I

    Clin. Genet.

    (2018)
  • S. Bretaud et al.

    p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson’s disease

    J. Neurochem.

    (2007)
  • G.C. Brown

    The endotoxin hypothesis of neurodegeneration

    J. Neuroinflamm.

    (2019)
  • C.E. Buckley et al.

    Zebrafish myelination: a transparent model for remyelination?

    Dis. Models Mech.

    (2008)
  • D.J. Burrows et al.

    Animal models of multiple sclerosis: from rodents to zebrafish

    Mult. Scler. J.

    (2019)
  • Cited by (24)

    View all citing articles on Scopus
    1

    Contributed equally to this study.

    View full text